Profound Medical Corp. Stocks Rise Slightly Amid Tight Price Range and Rising Oncology Device Demand
Profound Medical trades near its 200‑day SMA, offering a niche prostate‑cancer device strategy; investors watch clinical milestones for upside.
3 minutes to read